分析淋巴結可有效預測大腸癌復發(fā)幾率(3)
2011-02-16 17:40
閱讀:2392
來源:愛愛醫(yī)編輯部
作者:水**南
責任編輯:水北天南
[導讀] 根據(jù)杰弗遜金梅爾癌癥中心研究人員2月9日在《臨床癌癥研究》上公布了一項新研究表明,定量、分子分析患者淋巴結可以有效預測大腸癌的復發(fā)幾率
The researchers had previously concluded that expression of GUCY2C increased risk of recurrence. However, it is apparent that nodal metastases do not assure recurrence; rather they indicate risk.
The researchers found that patients with greater occult tumor burden have a greater risk of recurrence compared to patients with less burden. Thus, molecular tumor burden in lymph nodes are independently associated with time to recurrence and disease-free survival in patients with node-negative colorectal cancer.
"This approach can improve prognostic risk stratification and chemotherapeutic allocation in pN0 patients," the authors write. "More generally, this study reveals a previously unappreciated paradigm to advance cancer staging, clinically translating emerging molecular platforms that complement histopathology, laboratory diagnostic, and imaging modalities."
版權聲明:
本站所注明來源為"愛愛醫(yī)"的文章,版權歸作者與本站共同所有,非經(jīng)授權不得轉載。
本站所有轉載文章系出于傳遞更多信息之目的,且明確注明來源和作者,不希望被轉載的媒體或個人可與我們
聯(lián)系zlzs@120.net,我們將立即進行刪除處理